Đánh giá tác dụng điều trị tăng huyết áp độ I, I của viên nén thanh can HV trên lâm sàng

Abstract

Objectives: To evaluate the clinical effectiveness of "Thanh Can HV" in the treatment of hypertension grade I, II. Research subjects: Patients aged 18 years or older, regardless of gender, occupation, diagnosed as primary hypertension grade 1, 2 (according to 2018 recommendation criteria of the Vietnam Cardiology Association).

Methods: An open clinical intervention study, comparing before and after treatment with a control group.

Results: Using Thanh Can HV tablets to treat hypertensive patients for 28 days significantly reduced systolic blood pressure, diastolic blood pressure, and mean blood pressure; 100% of patients after using the drug had low blood pressure, in which the rate of achieving the target BP was 73.2%; The antihypertensive effect was similar to that of the control group using Amlodipine. Thanh Can HV tablets have better effect on improving clinical symptoms than Amlodipine, the effectiveness of Thanh Can HV tablets reaches 92.7%.